Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rigo

Showing results (91-100 of 163) with videos related to

Pageof 17
Sort By:
Cancer Research|December 18, 2021
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma GrowthWai Kit Ma, Dillon M Voss, Juergen Scharner, et al.
Neurobiology of Disease|November 21, 2018
Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 miceKrista J Spiller, Tahiyana Khan, Myrna A Dominique, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damageMohini Jangi, Christina Fleet, Patrick Cullen, et al.
Science Advances|August 22, 2025
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALSJacob Neeves, Marija Petrić Howe, Oliver J Ziff, et al.
Brain : a Journal of Neurology|July 3, 2018
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosisEva Janzen, Natalia Mendoza-Ferreira, Seyyedmohsen Hosseinibarkooie, et al.
Nature Neuroscience|June 4, 2021
Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTBRoy Maimon, Carlos Chillon-Marinas, Cedric E Snethlage, et al.
Molecular Therapy. Nucleic Acids|March 23, 2023
Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathiesPingting Liu, Wei Chen, Haowen Jiang, et al.
Nucleic Acids Research|December 28, 2020
The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administrationPaymaan Jafar-Nejad, Berit Powers, Armand Soriano, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2014
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesFrank Rigo, Seung J Chun, Daniel A Norris, et al.
Neuron|December 27, 2016
The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular AtrophyConstantin d'Ydewalle, Daniel M Ramos, Noah J Pyles, et al.
Pageof 17

Showing results (91-100 of 163) with videos related to

Sort By:
Pageof 17
Cancer Research|December 18, 2021
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma GrowthWai Kit Ma, Dillon M Voss, Juergen Scharner, et al.
Neurobiology of Disease|November 21, 2018
Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 miceKrista J Spiller, Tahiyana Khan, Myrna A Dominique, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damageMohini Jangi, Christina Fleet, Patrick Cullen, et al.
Science Advances|August 22, 2025
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALSJacob Neeves, Marija Petrić Howe, Oliver J Ziff, et al.
Brain : a Journal of Neurology|July 3, 2018
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosisEva Janzen, Natalia Mendoza-Ferreira, Seyyedmohsen Hosseinibarkooie, et al.
Nature Neuroscience|June 4, 2021
Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTBRoy Maimon, Carlos Chillon-Marinas, Cedric E Snethlage, et al.
Molecular Therapy. Nucleic Acids|March 23, 2023
Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathiesPingting Liu, Wei Chen, Haowen Jiang, et al.
Nucleic Acids Research|December 28, 2020
The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administrationPaymaan Jafar-Nejad, Berit Powers, Armand Soriano, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2014
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesFrank Rigo, Seung J Chun, Daniel A Norris, et al.
Neuron|December 27, 2016
The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular AtrophyConstantin d'Ydewalle, Daniel M Ramos, Noah J Pyles, et al.
Pageof 17